Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

BACKGROUND: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare hereditary kidney cancer syndrome in which affected individuals are at risk of skin and uterine leiomyomatosis and kidney cancer. HLRCC-associated kidney cancer is a lethal disease with a highly aggressive behavior, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Inkeun, Shim, Young Sup, Go, Heounjeong, Hong, Bum Sik, Lee, Jae Lyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558845/
https://www.ncbi.nlm.nih.gov/pubmed/31182090
http://dx.doi.org/10.1186/s12894-019-0484-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558845/
https://www.ncbi.nlm.nih.gov/pubmed/31182090
http://dx.doi.org/10.1186/s12894-019-0484-2

Ejemplares similares